Early-onset endothelin receptor blockade in hypertensive heterozygous Ren-2 rats (Q79810191)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16807127%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

title

Early-onset endothelin receptor blockade in hypertensive heterozygous Ren-2 rats (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16807127%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

Ivana Vanecková

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16807127%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Herbert J Kramer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16807127%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Angela Bäcker

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16807127%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Stanislava Schejbalová

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16807127%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Zdena Vernerová

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16807127%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Václav Eis

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16807127%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Martin Opocenský

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16807127%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Pavel Dvorák

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16807127%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Ludek Cervenka

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16807127%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

publication date

16 May 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16807127%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

published in

Vascular Pharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16807127%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16807127%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16807127%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

163-170

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16807127%20AND%20SRC:MED&resulttype=core&format=json

ET(A) receptor blockade prevents increased tissue endothelin-1, vascular hypertrophy, and endothelial dysfunction in salt-sensitive hypertension

26 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.003

Early-onset but not late-onset endothelin-A-receptor blockade can modulate hypertension, cerebral edema, and proteinuria in stroke-prone hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.003

Synergistic effects of AT(1) and ET(A) receptor blockade in a transgenic, angiotensin II-dependent, rat model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.003

Salt-sensitive hypertension in (mREN-2)27 transgenic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.003

Effects of chronic excess salt ingestion. Modification of experimental hypertension in the rat by variations in the diet

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.003

Endogenous endothelin attenuates the pressor response to acute environmental stress via the ETA receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.003

Receptor-mediated release of endothelium-derived relaxing factor and prostacyclin from bovine aortic endothelial cells is coupled

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.003

Blockade of endothelin receptors attenuates end-organ damage in homozygous hypertensive ren-2 transgenic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.003

Chronic ETA receptor blockade attenuates cardiac hypertrophy independently of blood pressure effects in renovascular hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.003

ETA receptor blockade attenuates hypertension and decreases reactive oxygen species in ETB receptor-deficient rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.003

Cardiovascular effects of endothelin-1 and endothelin antagonists in conscious, hypertensive ((mRen-2)27) rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.003

Salt-sensitive hypertension in endothelin-B receptor-deficient rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.003

Endothelin is a potent mitogen for rat vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.003

ETA and ETB receptors differentially modulate afferent and efferent arteriolar responses to endothelin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.003

Dual constrictor and dilator actions of ET(B) receptors in the rat renal microcirculation: interactions with ET(A) receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.003

Bosentan for the treatment of pulmonary arterial hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.003

Role of endothelin ET(B) receptors in the renal hemodynamic and excretory responses to big endothelin-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.003

Historical review: Endothelin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.003

Role of endothelins in animal models of hypertension: focus on cardiovascular protection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.003

Selective Endothelin-A Versus Combined Endothelin-A/Endothelin-B Receptor Blockade in Rat Chronic Heart Failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.003

Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.003

Endothelin Inhibition: Novel Therapy for Prostate Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.003

Extrarenal ETB plays a significant role in controlling cardiovascular responses to high dietary sodium in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.003

Role of podocytes for reversal of glomerulosclerosis and proteinuria in the aging kidney after endothelin inhibition.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.003

Blockade of angiotensin II type 1 receptor and not of endothelin receptor prevents hypertension and cardiovascular disease in transgenic (mREN2)27 rats via adrenocortical steroid-independent mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.003

Renal damage is not improved by blockade of endothelin receptors in primary renin-dependent hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.003

Nephroprotective effects of the endothelin ET(A) receptor antagonist darusentan in salt-sensitive genetic hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.003

Endothelin antagonism with bosentan: a review of potential applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.003

Effect of Endothelin Blockade on Early Cardiovascular Remodeling in the One-Clip-Two-Kidney Hypertension of the Rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.003

ABT-627, a potent endothelin receptor A antagonist, inhibits ovarian carcinoma growth in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.003

Early endothelin-A receptor blockade decreases blood pressure and ameliorates end-organ damage in homozygous Ren-2 rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.003

Endothelin in the kidney in malignant phase hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.003

Proteinuria and glomerulosclerosis in the Sabra genetic rat model of salt susceptibility.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.003

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.003

Ontogenetic aspects of hypertension development: analysis in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.003

10.1016/J.VPH.2006.05.003

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16807127%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference